Similar articles for PMID: 18000937

Year	Number of Results
1962	1
1976	1
1997	1
1998	1
1999	1
2000	3
2001	1
2002	6
2003	5
2004	30
2005	43
2006	35
2007	44
2008	39
2009	29
2010	23
2011	12
2012	16
2013	15
2014	6
2015	10
2016	5
2017	4
2018	5
2019	9
2020	6
2021	3
2022	4
2024	0

1

Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding.

Priego EM, Pérez-Pérez MJ, von Frijtag Drabbe Kuenzel JK, de Vries H, Ijzerman AP, Camarasa MJ, Martín-Santamaría S. Priego EM, et al. ChemMedChem. 2008 Jan;3(1):111-9. doi: 10.1002/cmdc.200700173. ChemMedChem. 2008. PMID: 18000937

2

Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA. Baraldi PG, et al. J Med Chem. 2004 Mar 11;47(6):1434-47. doi: 10.1021/jm0309654. J Med Chem. 2004. PMID: 14998332

3

New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.

Baraldi PG, Preti D, Tabrizi MA, Fruttarolo F, Romagnoli R, Zaid NA, Moorman AR, Merighi S, Varani K, Borea PA. Baraldi PG, et al. J Med Chem. 2005 Jul 14;48(14):4697-701. doi: 10.1021/jm058008c. J Med Chem. 2005. PMID: 16000006

4

Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as adenosine receptor antagonists.

Pastorin G, Bolcato C, Cacciari B, Kachler S, Klotz KN, Montopoli C, Moro S, Spalluto G. Pastorin G, et al. Farmaco. 2005 Aug;60(8):643-51. doi: 10.1016/j.farmac.2005.04.012. Farmaco. 2005. PMID: 15961085

5

2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.

Lenzi O, Colotta V, Catarzi D, Varano F, Poli D, Filacchioni G, Varani K, Vincenzi F, Borea PA, Paoletta S, Morizzo E, Moro S. Lenzi O, et al. J Med Chem. 2009 Dec 10;52(23):7640-52. doi: 10.1021/jm900718w. J Med Chem. 2009. PMID: 19743865

6

Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.

Rodríguez-Borges JE, García-Mera X, Balo MC, Brea J, Caamaño O, Fernández F, López C, Loza MI, Nieto MI. Rodríguez-Borges JE, et al. Bioorg Med Chem. 2010 Mar 1;18(5):2001-9. doi: 10.1016/j.bmc.2010.01.028. Epub 2010 Jan 15. Bioorg Med Chem. 2010. PMID: 20137957

7

1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.

Fernández F, Caamaño O, Isabel Nieto M, López C, García-Mera X, Stefanachi A, Nicolotti O, Isabel Loza M, Brea J, Esteve C, Segarra V, Vidal B, Carotti A. Fernández F, et al. Bioorg Med Chem. 2009 May 15;17(10):3618-29. doi: 10.1016/j.bmc.2009.03.062. Epub 2009 Apr 5. Bioorg Med Chem. 2009. PMID: 19398343

8

The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.

Cheong SL, Dolzhenko A, Kachler S, Paoletta S, Federico S, Cacciari B, Dolzhenko A, Klotz KN, Moro S, Spalluto G, Pastorin G. Cheong SL, et al. J Med Chem. 2010 Apr 22;53(8):3361-75. doi: 10.1021/jm100049f. J Med Chem. 2010. PMID: 20307065

9

Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.

Balo MC, Brea J, Caamaño O, Fernández F, García-Mera X, López C, Loza MI, Nieto MI, Rodríguez-Borges JE. Balo MC, et al. Bioorg Med Chem. 2009 Sep 15;17(18):6755-60. doi: 10.1016/j.bmc.2009.07.034. Epub 2009 Jul 23. Bioorg Med Chem. 2009. PMID: 19682912

10

2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.

Chang LC, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Mulder-Krieger T, Brussee J, Ijzerman AP. Chang LC, et al. J Med Chem. 2006 May 18;49(10):2861-7. doi: 10.1021/jm050640i. J Med Chem. 2006. PMID: 16686529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

323 results

Results by year